Johnson & Johnson Medical GmbH, a German company of the international Johnson & Johnson Medical Devices Companies, has acquired the software company Surgical Process Institute (SPI). The acquisition complements the surgical portfolio with solutions for optimizing workflows in the operating theatre. The parties have agreed not to disclose the financial terms of the transaction.
Every year, millions of surgeries are performed around the world. Surgeons usually follow the exact same steps to ensure consistent positive results for patients. However, successful surgery is not only dependent on the surgeons’ performance but also on many steps during a procedure with diverse surgical teams that seamlessly work together.
SPI has developed a way of standardizing surgeries by translating the entire surgical experience into a detailed, step-by-step checklist that follows best-in-class standards. This means that important safety checks are completed every time in the same order and all supporting processes are harmonized.
Surgical Process Institute (SPI) offers innovative software solutions to improve patient outcomes and operating room efficiency by reducing variability in surgical interventions. The institute’s vision is to establish optimal medical standards in order to ensure the best medical quality and economic efficiency.
The team consists of business economists, process and certification specialists, IT and medical technology experts, architects, marketing specialists and a network of experienced physicians.
Surgical Process Institute Deutschland GmbH, based in Leipzig, Germany, is an ISO 9001:2015 certified company.
Johnson & Johnson Medical Devices has an extensive range of products, services and programs as well as expertise in research and development in the fields of surgical technology, orthopedics, cardiovascular and special medical services.
In Germany, Johnson & Johnson is represented by various companies and spread across several locations. In total, they employ over 4,000 people in Germany. The two largest locations are Norderstedt as a subsidiary of the Medical Devices sector and Neuss for the Pharmaceuticals and Consumer sectors.
March 23, 2018
Quarton advises Medartis on its IPO on SIX Swiss Exchange